Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124332782 | 12433278 | 2 | F | 20160729 | 20160603 | 20160808 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00904 | WESTWARD | JAMES A,LARSON T. ACUTE RENAL FAILURE AFTER HIGH-DOSE ANTIBIOTIC BONE CEMENT: CASE REPORT AND REVIEW OF THE LITERATURE. RENAL FAILURE 2015;37(6):1061-1066. | 69.00 | YR | F | Y | 0.00000 | 20160808 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124332782 | 12433278 | 1 | PS | LISINOPRIL. | LISINOPRIL | 1 | Unknown | Y | 76063 | ||||||||||
| 124332782 | 12433278 | 2 | SS | PIPERACILIN/TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | Y | 0 | ||||||||||
| 124332782 | 12433278 | 3 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Unknown | 0 | 10.8 | G | |||||||||
| 124332782 | 12433278 | 4 | SS | TOBRAMYCIN. | TOBRAMYCIN | 1 | Unknown | 0 | 3.6 | G | |||||||||
| 124332782 | 12433278 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | Y | 0 | 1 | G | BID | |||||||
| 124332782 | 12433278 | 6 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | Y | 0 | 750 | MG | BID | |||||||
| 124332782 | 12433278 | 7 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | Y | 0 | 12 | G | ||||||||
| 124332782 | 12433278 | 8 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | Y | 0 | 4 | G | ||||||||
| 124332782 | 12433278 | 9 | C | DULOXETINE. | DULOXETINE | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 10 | C | SOLIFENACIN | SOLIFENACIN | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 12 | C | HYDROCODONE/PARACETAMOL | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 13 | C | MORPHINE | MORPHINE | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 14 | C | PAROXETINE. | PAROXETINE | 1 | Unknown | 0 | |||||||||||
| 124332782 | 12433278 | 15 | C | RIFAMPICIN | RIFAMPIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124332782 | 12433278 | 1 | Product used for unknown indication |
| 124332782 | 12433278 | 2 | Product used for unknown indication |
| 124332782 | 12433278 | 3 | Knee arthroplasty |
| 124332782 | 12433278 | 5 | Product used for unknown indication |
| 124332782 | 12433278 | 9 | Product used for unknown indication |
| 124332782 | 12433278 | 10 | Product used for unknown indication |
| 124332782 | 12433278 | 11 | Product used for unknown indication |
| 124332782 | 12433278 | 12 | Product used for unknown indication |
| 124332782 | 12433278 | 13 | Product used for unknown indication |
| 124332782 | 12433278 | 14 | Product used for unknown indication |
| 124332782 | 12433278 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124332782 | 12433278 | HO |
| 124332782 | 12433278 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124332782 | 12433278 | Acute kidney injury | |
| 124332782 | 12433278 | Haemoglobin decreased | |
| 124332782 | 12433278 | Hypotension | |
| 124332782 | 12433278 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |